Product
IMGC936
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGC936 (Anti-ADAM9 Antibody Drug Conjugate) in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2023-12-31